TR201203341A2 - Ranolazin sürekli salım tableti. - Google Patents
Ranolazin sürekli salım tableti.Info
- Publication number
- TR201203341A2 TR201203341A2 TR2012/03341A TR201203341A TR201203341A2 TR 201203341 A2 TR201203341 A2 TR 201203341A2 TR 2012/03341 A TR2012/03341 A TR 2012/03341A TR 201203341 A TR201203341 A TR 201203341A TR 201203341 A2 TR201203341 A2 TR 201203341A2
- Authority
- TR
- Turkey
- Prior art keywords
- sustained release
- release tablet
- ranolazine sustained
- ranolazine
- ranolase
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Ranolazın içeren sürekli salım tableti ile ilgilidir. Salım kontrol ajam olarak hıdroksıpropil metilselüloz asetat suksinat ve yağ asidi esten veya alkolü içerir.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2012/03341A TR201203341A2 (tr) | 2012-03-23 | 2012-03-23 | Ranolazin sürekli salım tableti. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2012/03341A TR201203341A2 (tr) | 2012-03-23 | 2012-03-23 | Ranolazin sürekli salım tableti. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201203341A2 true TR201203341A2 (tr) | 2012-12-21 |
Family
ID=47679792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2012/03341A TR201203341A2 (tr) | 2012-03-23 | 2012-03-23 | Ranolazin sürekli salım tableti. |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR201203341A2 (tr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017001669A1 (en) | 2015-07-02 | 2017-01-05 | Interquim, S.A. | Ranolazine multiple compressed tablets |
WO2018001582A1 (en) | 2016-06-30 | 2018-01-04 | Interquim, S.A. | Ranolazine multiple compressed tablets |
-
2012
- 2012-03-23 TR TR2012/03341A patent/TR201203341A2/tr unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017001669A1 (en) | 2015-07-02 | 2017-01-05 | Interquim, S.A. | Ranolazine multiple compressed tablets |
WO2018001582A1 (en) | 2016-06-30 | 2018-01-04 | Interquim, S.A. | Ranolazine multiple compressed tablets |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWD163742S (zh) | 顯示螢幕的圖像 | |
TWD163744S (zh) | 顯示螢幕的圖像 | |
EP3088429A4 (en) | Modified polyvinyl alcohol and water-soluble film containing same | |
IN2015MN00020A (tr) | ||
AR096975A1 (es) | Formulación líquida en aerosol de un artículo electrónico para fumar | |
CL2014001930A1 (es) | Formulacion farmacéutica que comprende un anticuerpo angiopoyetina 2 (anti-ang2). | |
BR112015021410A2 (pt) | inibidores macrocíclicos das interações das proteína/proteína pd-1/pd-l1 e cd80(b7-1)/pd-l1 | |
HUE049076T2 (hu) | Módosított polivinil-akohol, és az azt tartalmazó vízoldható film | |
TWD163749S (zh) | 顯示螢幕的圖像 | |
TWD164803S (zh) | 顯示螢幕之圖像 | |
TWD158424S (zh) | 音訊揚聲器系統之部分 | |
MX2020003096A (es) | Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif. | |
EP3060681A4 (en) | Genetic markers predictive of response to glatiramer acetate | |
AU345217S (en) | Fire detector | |
TWD156928S (zh) | 化妝品展示台 | |
TWD163743S (zh) | 顯示螢幕的圖像 | |
UY34786A (es) | Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo | |
BR112015014853A2 (pt) | Formulação farmacêutica, formulação farmacêutica liofilizada, uso de uma formulação farmacêutica e artigo de manufatura | |
UY34842A (es) | Formulaciones estabilizadas que contienen anticuerpos anti-dll4 | |
TWD163738S (zh) | 顯示螢幕之圖像 | |
AR093402A1 (es) | Producto de comicronizacion que comprende acetato de ulipristal | |
EP3011061A4 (en) | VIRION DISPLAY MATRIX FOR PROFILING THE FUNCTIONS AND INTERACTIONS OF HUMAN MEMBRANE PROTEINS | |
BR112013010709A2 (pt) | derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo | |
TWD163740S (zh) | 顯示螢幕的圖像 | |
EA201591787A1 (ru) | Таблетки совапревира |